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Objectives: In sleep laboratory studies, the new environment is generally considered to 
disturb sleep during the first night.  However, older women have rarely been studied. 
Although menopause and hormone therapy affect sleep, their effect on the first night effect is 
virtually unknown.  
Participants: Four groups of women with no sleep laboratory experience: young on hormonal 
contraceptives (n=11, 23.1 (0.5) years), perimenopausal (n=15, 48.0 (0.4) years), 
postmenopausal without hormone therapy (HT) (off-HT, n=22, 63.4 (0.8) years) and 
postmenopausal with HT (n=16, 63.1 (0.9) years).  
Procedure: A cross-sectional study. 
Methods: Polysomnography was performed over two consecutive nights and the first night 
effect and group differences were evaluated. Questionnaire-based insomnia and sleepiness 
scores were correlated to sleep variables and their between-night changes. 
Results: Although sleep in young women was deeper and less fragmented than in the other 
groups, first night effect was similar in all study groups. Total sleep time, sleep efficiency, 
and S1 and S2 sleep increased, and wake after sleep onset, awakenings per hour of sleep, S2 
and REM latencies, and percentage of SWS decreased from the first to the second night. 
Perimenopausal women had more insomnia complaints than other women. Insomnia 
complaints were associated with more disturbed sleep but not with the first night effect.  
Conclusions: A first night in a sleep laboratory elicits a marked interference of sleep 
architecture in women of all ages, with a carry-over effect of lighter sleep on the second 





The first night effect, i.e. disturbed sleep during the first laboratory polysomnography (PSG) 
night, was first described by Agnew et al (1966). They observed more awake periods, less 
rapid eye movement (REM) sleep, a delay in the onset of both slow wave sleep (SWS) and 
REM sleep, and an increase in sleep stage transitions during a first laboratory night. In 
healthy adults and elderly people, literature is consistent that sleep efficiency (SE), total sleep 
time (TST), and the amounts of SWS and REM sleep are decreased, sleep latency (SL) and 
REM latency are prolonged, and light sleep (S1 / N1) and wake time are increased during a 
first night in a sleep laboratory (Curcio, Ferrara, Piergianni, Fratello, & De Gennaro, 2004; 
Kis et al., 2014; Newell, Mairesse, Verbanck, & Neu, 2012; Toussaint et al., 1995; Webb & 
Campbell, 1979; Zheng et al., 2012) or even in PSG recordings conducted at home 
(Wauquier, van Sweden, Kerkhof, & Kamphuisen, 1991). The first night effect is crucial 
especially in studies investigating the effects of e.g. different medications or sleep deprivation 
on PSG parameters. In such studies comparative baseline night before the interventions is 
needed which should be free from disturbances like being unaccustomed to sleep 
environment. It has been suggested that the first night effect may actually last for several 
nights (Le Bon et al., 2001), but a study by Lorenzo and Barbanoj ( 2002) proposed that the 
first night effect is literally confined to the first night in a sleep laboratory.  
 
Regardless of a fairly large database, only two studies have focused on first night effect 
exclusively in women. Webb and Campbell ( 1979) observed a more pronounced first night 
effect in older women, but they did not define their reproductive state. The Study of 
Women’s Health Across the Nation (SWAN) (Zheng et al., 2012) studied groups of peri- and 
postmenopausal women and found shorter TST, lower SE, less REM sleep and delta activity, 
a longer SL and more wake after sleep onset (WASO) during the first night. They did not 
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include young, fertile women or HT users and therefore, information on the influence of 
different female reproductive states on first night effect is lacking. Studying the first night 
effect in different female reproductive states is justified given that sleep quality in women 
deteriorates with age (Kalleinen et al., 2006), and many studies show that sleep quality is 
worse in the perimenopause and postmenopause, especially in women with climacteric 
vasomotor symptoms (Lampio et al., 2014; Polo-Kantola, 2011; Shaver, Giblin, Lentz, & 
Lee, 1988; Young, Rabago, Zgierska, Austin, & Finn, 2003). HT is the first line treatment for 
climacteric vasomotor symptoms (de Villiers et al., 2013) and thus sleep, especially insomnia 
symptoms, also improves during HT (Polo-Kantola, 2011). Furthermore, HT has been shown 
to ameliorate the sleep disruption elicited by nocturnal blood sampling, which can be 
compared to the disturbance elicited by PSG electrodes in study-naïve individuals (Moe, 
Larsen, Vitiello, & Prinz, 2001). 
 
Based on the above rationale, we set up to investigate the first night effect and its possible 
differences in female reproductive states from early adulthood to late postmenopause, with 
the addition of the effect of HT. We hypothesized that the changes in hormonal levels due to 
menopause and the use of HT in postmenopause could influence the ability to adapt to a 




The study was a part of a larger study exploring the effects of ageing, hormonal state and HT 
on sleep and cognition. The study was performed in the Universities of Turku and Helsinki, 
Finland. The Turku Sleep Research Unit served as the supervising and monitoring unit of the 
study. Perimenopausal and postmenopausal women were recruited from the Turku area 
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through newspaper announcements, and young women from Helsinki by announcement at the 
university. Exclusion criteria consisted of existing cardiovascular (hypertension controlled 
with medication was accepted), pulmonary, neurological, endocrinological or mental disease, 
irregular or delayed sleep schedule and specific sleep disorders, such as sleep apnea, 
narcolepsy or restless legs syndrome. Women suffering from conditions that could affect 
sleep, like fibromyalgia and anemia, were excluded. Other exclusion criteria included the use 
of medication affecting the central nervous system, including sleeping pills, alcohol abuse, 
smoking and excessive caffeine intake (over 5 cups of coffee per day). Starting one week  
before the study,  caffeine  and   alcohol  use was  prohibited. Before the study, blood 
hemoglobin, leucocytes, thrombocytes and serum thyrotropin levels were measured and 
required to fall within normal ranges. Regular medication was used by 15 peri- and 
postmenopausal women: four women used salicylates, five used statins and ten used 
antihypertensive medications (beta blockers, calcium blockers, AT1-receptor antagonists, or 
diuretics). None of the study subjects had sleep laboratory experience. 
 
Information about the study and screening for exclusion criteria was given during a 10–30 
min telephone interview (P.P-K., N.K.). Women meeting inclusion criteria were invited for a 
clinical interview and physical examination (duration 1–1.5 h, P.P-K.) in which exclusion 
criteria were re-screened and study information was provided. Mood disorders were excluded 
by filling in the Beck Depression Inventory (BDI). The study protocol is described in detail in 
previous reports by Kalleinen et al. (2008; 2006). The women kept a sleep diary three weeks 
before and one week after the sleep studies to ensure a regular sleep-wake schedule required 
for inclusion (from 22:00-23:00 hr to 06:00-07:00 hr). Before the study, the participants also 
filled in the validated and widely used Basic Nordic Sleep Questionnaire (BNSQ) (Partinen 
& Gislason, 1995), from which the sums of insomnia and sleepiness scores were calculated. 
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Climacteric symptomatology was scored before the first night with questions on the 
frequency of night sweats and hot flashes during the last six months in a scale of 1 to 4 
(1=seldom or never, 2=once a month, 3=once a week, 4=almost every day). No group 
differences in symptom scores were observed. Background information is shown in Table 1.  
 
Of those recruited to the study, 17 were perimenopausal, 44 postmenopausal and 11 young 
women. Women were defined as perimenopausal if serum FSH levels were lower than 23 
IU/L and they had ongoing regular or irregular menstrual cycle, whereas postmenopausal 
women were defined by age over 57 years and chronic amenorrhea of more than one year.  
Perimenopausal women [aged 47.7 (0.5) years] did not use HT. Sixteen postmenopausal 
women [aged 63.1 (0.9) years] used HT (on-HT group, oral n=10, continuous combined, 
estradiol hemihydrate 2 mg + norethisterone acetate 1 mg or transdermal n=6, 17-estradiol 
50 µg/24 h + norethisterone acetate 250 mg/24 h patch), for a mean time of 12.0 (1.2) years. 
Twenty-eight postmenopausal women had either never used HT (n=8) or had a time since 
discontinuation of at least 12 months with 5.7 (1.0) years of previous use [off-HT group, aged 
63.9 (0.8) years]. In both on-HT and off-HT groups, three women had undergone surgical 
menopause (minimum six years prior to the study). Young women [aged 23.1 (0.5) years] 
used oral contraceptives (ethinyl estradiol 20 μg + desogestrel 0.15 mg). Perimenopausal and 
young women were examined during the first days of their menstrual cycle. Due to 
insufficient data, we were able to analyse recordings from 10 young women [aged 23.0 (0.5) 
years], 15 perimenopausal women [aged 48.0 (0.4) years], 22 postmenopausal women off-HT 





For plasma follicle stimulating hormone (FSH) and serum estradiol (E2) measurements, a 
blood sample was drawn in the morning following the first night to ensure appropriate use of 
HT. Height and weight were measured and body mass index (BMI) was calculated 
accordingly. The Sleep Research Unit provided pre-arranged, nutritionally similar meals and 
caffeine free coffee or tea served at specific times for the subjects during the study.  
 
PSG was performed over two consecutive nights from 11 pm to 7 am. In all women, the PSG 
recordings comprised continuous monitoring of two electroencephalograms (EEG, C3/A2, 
C4/A1), two electro-oculograms (EOG), a mandibular electromyogram (EMG) and an 
electrocardiogram (ECG) with a sampling frequency of 200 Hz. In addition, the 
perimenopausal and postmenopausal women had two additional EEG channels (O1/A2, 
O2/A1). (Embla, Medcare Flaga hf. Medical devices, Reykjavik, Iceland). The mean 
analysed time was 478.9 ± 0.9 min during first nights, and 479.9 ± 0.2 min during second 
nights (p=ns). All recordings were visually double-scored in 30 s epochs off-line by 
experienced scorers (N.K., P.P.-K. and I.V.) according to the Rechtschaffen and Kales 
criteria (1968) valid during data collection (years 2001-2004). Three non-REM (NREM) 
sleep stages [stage 1 (S1), stage 2 (S2), SWS (stages 3 and 4 combined)] and REM sleep, as 
well as wake and movement time (MT), were classified and expressed as minutes and per 
cent of total sleep time (TST). Additionally, SE (TST as per cent of total recording time), SL 
(from lights off to sleep onset, defined as the appearance of three consecutive epochs of S1 or 
the first epoch of any other stage), latency to the first 30 seconds of S2, SWS and REM sleep 
from sleep onset, wake after sleep onset (WASO) and awakening index (the number of 
awakenings per hour of sleep) were calculated.  
 
Statistical analysis  
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Statistical analyses were made using the IBM SPSS® ver. 22.0 software. Data were first 
tested for normality and observed to be highly skewed, and accordingly, differences between 
groups in sleep variables were analysed at both nights and for the first night effect using the 
independent samples Kruskall-Wallis test. Post-hoc analyses were made using the Mann-
Whitney U-test with Bonferroni correction. First night effect was then analysed both using 
combined groups and group-wise using the Wilcoxon signed rank test. Spearman correlation 
coefficients were calculated between the BNSQ insomnia and sleepiness scores, vasomotor 
symptom scores, serum FSH levels, and the objective sleep variables during both nights. To 
tease out a possible reverse first night effect and hormonal effects, same correlations were 
applied to inter-night differences in sleep variables. All results are expressed as mean (SEM). 
P values of <0.05 were considered significant. 
 
Ethics 
The study was approved by the Ethical Committees of Turku University Central Hospital and 
University of Helsinki. All the study participants gave their written informed consent. 
 
Results 
Group differences on first night 
During the first night, young women had less S1 and more SWS than other groups. They also 
had a longer TST, less WASO, and a lower awakening index than the postmenopausal 
groups. Furthermore, young women had less wake time, a higher SE and more REM sleep 
than the off-HT group. Perimenopausal women had more REM sleep than postmenopausal 
off-HT women. Between postmenopausal groups, off-HT women had more SWS than on-HT 




Group differences on second night 
During the second night, young women had a longer REM latency, more SWS, less WASO 
and a lower awakening index than other women. In addition, they had a longer TST, higher 
SE, and less wake time than the postmenopausal groups, as well as less S1 and S2 than the 
on-HT postmenopausal women. Perimenopausal women had less S1 than on-HT 
postmenopausal women, and the off-HT group had more SWS than the on-HT group during 
the second night. (Table 2)  
 
First night effect in combined groups 
When sleep variables were analysed using combined groups, SE increased from the first night 
of 81.9 % (1.5 %) to the second night of 87.1 % (1.0 %). WASO decreased from 66.6 (6.0) 
min to 44.6 (4.5) min, and awakening index decreased from 3.22 (0.31) to 2.20 (0.17). Sleep 
latency, S2 latency and REM latency decreased from 20.4 (2.6) min to 15.1 (1.6) min, from 
5.5 (0.9) min to 4.0 (1.3) min, and from 102.3 (6.6) min to 80.1 (3.7) min, respectively. S1 
and S2 percentages increased between nights from 6.5 (0.5) % to 10.0 (0.5) % and 44.1 (0.9) 
% to 50.1 (1.0) %, respectively, while the SWS percentage decreased from 25.1 (0.8) % to 
16.0 (0.9) %. All these changes were significant at p<0.010.  
 
First night effect in separate groups and group effect 
In group-wise analysis, the amounts of S1 and S2 increased and the amount of SWS 
decreased in all groups between the first and second nights. The amount of wake time and 
WASO decreased and SE increased in all groups but not in on-HT postmenopausal women. 
Further, REM latency decreased in perimenopausal and off-HT postmenopausal women, 
awakening index decreased in young and off-HT women, and S2 latency decreased in off-HT 
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women. (Table 2, Figure 1, Figure 2). In the between-groups Kruskall-Wallis test for the first 
night effect, no group differences were found in any of the measured variables.  
 
Objective sleep disturbance vs subjective symptoms and hormone profiles 
Perimenopausal women had higher insomnia scores than any other group (p<0.05 for all). 
Higher insomnia scores were associated with lower TST and SE, and higher wake and 
WASO at p<0.01, and higher percentage of S1 sleep at p<0.05 during both nights. Absolute 
REM sleep time was lower with higher insomnia scores at p<0.01 during the first night and at 
p<0.05 during the second night. Further, during the first night, lower REM percentage 
(p<0.01) and higher awakening index (p<0.05) were associated with higher insomnia scores. 
Higher sleepiness scores were associated with shorter SL during the first, but not the second, 
night at p<0.05. However, the insomnia or sleepiness scores were not associated with any 
changes in sleep variables between nights.  
Women with more vasomotor symptoms had higher awakening indexes during the first night 
(p<0.01). During the second night, they had lower TST and SE (p<0.01), less S2 and REM 
sleep (p<0.05) and more WASO (p<0.05) and wake time (p<0.01).  
Higher FSH levels were associated with more S2 sleep and WASO (p<0.05) and less REM 
sleep (p<0.01) during the first night. During the second night, higher FSH levels correlated 
with lower TST and SE and more wake time, WASO and awakenings (p<0.05 for all).  
No associations of vasomotor symptoms or FSH levels with inter-night differences were 
observed. 
Insomnia scores and FSH levels were strongly correlated (p<0.001). Vasomotor symptoms 





To our knowledge, our study was the first to evaluate the effect of female reproductive states 
on first night effect. We found that sleep efficiency increased and WASO and awakenings 
decreased, thus supporting the idea of an adaptation night in laboratory-based sleep studies. 
We also discovered an increase in both S1 and S2 and a decrease in SWS from the first to the 
second night, suggesting that the sleep disturbance persists over the second night.  The 
changes were consistent in each group within their own variability limits, albeit less marked 
sleep consolidation was seen in women using HT.  
 
Previously, SE has been shown to decrease, TST shorten, WASO increase, and SL and REM 
latency lengthen during a first PSG night in populations aged 2-93 years (Buckley et al., 
2013; Curcio et al., 2004; Kis et al., 2014; Moser, Kloesch, Fischmeister, Bauer, & 
Zeitlhofer, 2010; Newell et al., 2012; Prihodova et al., 2010; Scholle et al., 2003; Toussaint et 
al., 1995; Wauquier et al., 1991; Zheng et al., 2012). Tamaki et al 2005) also showed a slower 
and more fragmented sleep onset during a first night in a sleep laboratory. Lighter sleep 
during the second night in our study cohort was intriguing, as previously most studies agree 
on more SWS (Kis et al., 2014; Newell et al., 2012; Scholle et al., 2003; Wauquier et al., 
1991; Zheng et al., 2012) and slow wave activity (Tamaki et al., 2005; Toussaint et al., 1995), 
and less S1 / N1 sleep (Curcio et al., 2004; Scholle et al., 2003) during a second night in a 
sleep laboratory. However, Buckley et al ( 2013) observed decreased N2 sleep in children, 
and Curcio et al (2004) increased EEG delta power in adults during a first laboratory night. In 
our study, changes were uniform and of the same magnitude in all groups. When the 
proportions of sleep stages were compared, the longer wake time observed during the first 
night was reduced and replaced by S1 and S2 sleep during the second night. The observed 
decrease in the proportion of SWS from the first to the second night may therefore be partly 
due to the increased amount of total sleep. This suggests that a laboratory environment may 
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in fact disturb the lighter stages of sleep more whereas SWS deprivation is more negligible. 
Therefore, there would be no necessity to increase the amount of SWS, but rather to increase 
the total amount of sleep. The finding poses a question on whether one adaptation night is 
enough. A previous report by Le Bon et al ( 2001) suggests that this may be true. In their 
study group of 26 young volunteers, the effects of a first night on NREM sleep lasted for one 
night, but REM sleep power bands increased and REM latencies decreased up until the fourth 
night. The different result profile may be affected by the age difference and the fact that their 
cohort was half male.   
 
In our study, sleep in young women was deeper and more consolidated than in other groups, 
but in the peri- and postmenopausal women it was quite similar. At least three large 
population-based studies have addressed the effects of midlife reproductive state on objective 
sleep quality (Hachul et al., 2010; Hachul et al., 2015; Young et al., 2003), showing that peri- 
and postmenopausal women have more SWS and less REM sleep than premenopausal 
women, even when adjusting for age. Sleep in postmenopausal HT users is less fragmented 
and less prone to external disturbance than sleep in non-users (Hachul et al., 2010; Moe et al., 
2001; Young et al., 2003). Further, according to our results higher serum FSH concentrations 
are associated with more fragmented sleep. Symptomatic perimenopausal women also have 
worse sleep quality that is improved by HT (Polo-Kantola, 2011; Shaver et al., 1988; Young 
et al., 2003), which is in line with our observation on more fragmented sleep in women with 
more vasomotor symptoms. However, HT users have more S1 sleep and less SWS than non-
HT-users (Young et al., 2003). This agrees with our findings of less SWS in HT users 
compared to non-users during both nights. Lighter sleep in on-HT women might be 
interpreted as a deteriorative effect of HT on sleep. However, since the use of HT was self-
chosen, it is more likely that HT users were initially more symptomatic than off-HT women. 
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Therefore, their sleep could be more vulnerable for outside stressors, being beyond the 
alleviating effect of HT.  
 
Subjective and objective sleep disturbances correlate less in postmenopausal women than in 
men or premenopausal women, especially in symptomatic women (Vitiello, Larsen, & Moe, 
2004; Young et al., 2003). In HT users, the correlation between objective and subjective sleep 
quality is negligible (Vitiello et al., 2004). As insomnia scores varied between groups, we 
further estimated the possible association of subjective sleep disturbance with sleep variables. 
Our sample size did not allow for reliable group-wise correlation analyses, but groups 
combined, complaints of insomnia were associated with lighter and more fragmented sleep, 
thus linking subjective and objective sleep disturbance together. Furthermore, as some 
insomnia patients seem to exhibit a reverse first night effect (RFNE) (Hauri & Olmstead, 
1989; Riedel, Winfield, & Lichstein, 2001), we looked for correlations between insomnia 
scores and the observed first night effect, but no associations were observed. This suggests 
that RFNE did not affect our results. 
 
There are some limitations in our study. First, only central EEG electrodes were used in 
young women due to limited resources at the Helsinki study site. This limits the assessment 
of posterior alpha activity with possible difficulties in the differentiation between wake and 
drowsiness (Santamaria & Chiappa, 1987). However, as their EEG patterns were clear, it 
very unlikely formed any error in the sleep stage analysis. Second, since the sleep data were 
collected and analysed between 2001 and 2004, the sleep stage analysis was performed using 
the Rechtschaffen and Kales criteria (Rechtschaffen & Kales, 1968), instead of the AASM 
criteria (Iber, Ancoli-Israel, Chesson, & Quan, 2007). This may lead to overestimation of 
S2/N2 sleep and underestimation of S1/N1 sleep and SWS in our data (Moser et al., 2009). 
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As the difference was consistent across groups and nights, it unlikely formed any error to the 
interpretation. The long data gathering time also made it impossible to control for ambient 
light or time of year. Also, sleep macroarchitechture may not be a sensitive enough marker, 
and analysing sleep microarchitecture might have given additional information. Third, while 
we excluded women with previous diagnosis of sleep apnea and restless legs syndrome, we 
did not use leg electrodes or nasal pressure transducers. Therefore, undiagnosed diseases 
could not be ruled out. Fourth, all young women used oral contraceptives, which have some, 
albeit divergent, effects on sleep (Baker, Mitchell, & Driver, 2001; Hachul et al., 2010) and 
thus their results are possibly not comparative with women not using contraceptives. Fifth, 
the women in our study were relatively healthy, and therefore, the results cannot be 
generalised to a general population. Last, as is typical in PSG studies, our patient groups are 




Our study shows a distortion of PSG measured sleep of women in the first night in sleep 
laboratory. This distortion is prolonged to the second night as lighter objective sleep. 
Regardless of age-mediated changes in sleep architecture, a first night in a sleep laboratory 
produces very consistent changes in both sleep consolidation and the proportions of sleep 
stages in women of different ages. This change appears to be unaffected by menopausal 
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Figure 1. Sleep consolidation during study nights in the groups. Error bars in SEM.  p<0.05,  


























Figure 2. Sleep stage indexes during study nights in the groups. Error bars in SEM.  p<0.05,  






Table 1. Baseline data of the study groups. 
 




















           
Young women 23.1 ± 0.5 0 22.4 ± 0.7 ** 3.5 ± 0.8 ** 0.08 ± 0.02 § 10.0 ± 0.7 ** 10.3 ± 0.7 2,6 ± 0,3 1,5 ± 0,5 ** 
Perimenopausal women 48.0 ± 0.4 1,5 ± 0,3 24.2 ± 0.6 * 11.4 ± 1.3 ** 0.33 ± 0.09 ** 13.2 ± 1.0 * 9.8 ± 1.0 2,6 ± 0,2 3,9 ± 0,8  
Off-HT postmenopausal women 63.4 ± 0.8 2,4 ± 0,2 27.4 ± 1.1 
 
78.9 ± 7.1 
 
0.03 ± 0.00 
 
16.9 ± 0.6 
 
11.0 ± 0.7 3,7 ± 0,5 6,9 ± 0,9  
On-HT postmenopausal women 63.1 ± 0.9 1,7 ± 0,2 24.9 ± 0.6 
 
13.8 ± 4.0 ** 0.19 ± 0.03 * 13.4 ± 1.2 * 11.8 ± 1.4 2,6 ± 0,3 4,2 ± 0,9  
               
 
* p<0.05, ** p<0.01 compared to off-HT postmenopausal women 
§ p<0.05 compared to perimenopausal women 
BDI = Beck Depression Inventory 




Table 2. Sleep indexes in study groups.  
  Young, n = 10   Perimenopausal, n = 15   Postmenopausal, off-HT, n = 22   Postmenopausal, on-HT, n = 14   
  Night 1   Night 2   Night 1   Night 2   Night 1   Night 2   Night 1   Night 2   
  Mean ± SEM   Mean ± SEM   Mean ± SEM   Mean ± SEM   Mean ± SEM   Mean ± SEM   Mean ± SEM   Mean ± SEM   
                                  
Total sleep time min 439.2 ± 4.6   448.1 ± 9.0   397.7 ± 15.9   410.1 ± 10.8   371.4 ± 11.2 ** 389.1 ± 8.7 ** 383.5 ± 14.3 * 400.2 ± 8.4 ** 
Sleep efficiency of time analysed % 91.7 ± 1.0   94.7 ± 1.6   82.9 ± 3.3   88.0 ± 2.0   77.5 ± 2.3 % ** 84.0 ± 1.6 ** 80.5 ± 3.1   85.8 ± 1.7 ** 
Sleep latency min 14.6 ± 3.0   14.6 ± 3.0   19.4 ± 6.9   14.1 ± 3.1   22.6 ± 4.0   16.5 ± 3.1   22.2 ± 5.4   14.5 ± 3.4   
S2 latency from sleep onset min 18.5 ± 2.7   2.8 ± 1.4   25.7 ± 6.8   4.5 ± 3.0   28.2 ± 4.1   3.2 ± 1.8   5.6 ± 1.7   5.7 ± 3.6   
SWS latency from sleep onset min 24.9 ± 3.3   12.8 ± 2.1   37.5 ± 8.2   20.0 ± 4.0   42.8 ± 6.9   18.0 ± 3.8   14.5 ± 2.6   23.3 ± 5.2   
REM latency from sleep onset min 104.5 ± 11.8   111.4 ± 11.5   100.5 ± 10.6   74.9 ± 5.4 * 113.8 ± 14.2   76.2 ± 5.8 * 84.7 ± 10.5   69.6 ± 4.9 * 
S1 as % of TST 2.2 ± 0.2   6.4 ± 0.8   6.5 ± 0.7 ** 9.0 ± 0.7 %   7.3 ± 1.0 ** 10.6 ± 0.9   8.1 ± 0.9 ** 12.5 ± 0.9 ** # 
S2 as % of TST 40.2 ± 1.4   46.7 ± 1.0   43.6 ± 1.7   51.1 ± 2.3   44.6 ± 1.6   50.0 ± 1.6   46.7 ± 1.7   56.2 ± 1.4 ** 
SWS as % of TST 30.4 ± 1.4   24.4 ± 1.0   23.0 ± 1.8 * 15.5 ± 1.8 ** 26.9 ± 1.2   16.2 ± 1.5 ** 20.9 ± 1.5 ** § 10.2 ± 1.3 ** § 
REM as % of TST 27.2 ± 1.6   22.6 ± 1.3   26.8 ± 1.5   24.4 ± 1.6   21.2 ± 1.2 * # 23.3 ± 1.2   24.3 ± 1.3   21.0 ± 1.0   
Wake after sleep onset min 25.1 ± 4.3   10.5 ± 6.6   62.8 ± 11.3   41.5 ± 8.8 * 85.3 ± 10.0 ** 57.5 ± 7.0 ** 71.3 ± 13.4 * 52.1 ± 8.9 ** 
S1 min 9.5 ± 0.9   28.5 ± 3.9   25.6 ± 2.8 ** 36.5 ± 2.7   26.1 ± 2.7 ** 41.2 ± 3.6   30.3 ± 3.0 ** 50.2 ± 3.7 ** 
S2 min 176.4 ± 5.2   209.4 ± 6.5   172.0 ± 7.6   209.6 ± 11.1   166.2 ± 7.9   194.1 ± 7.3   178.3 ± 7.8   225.3 ± 8.2   
SWS min 133.6 ± 6.1   108.9 ± 4.2   92.0 ± 8.5 ** 62.9 ± 6.6 ** 99.0 ± 4.8 ** 63.6 ± 6.4 ** 79.9 ± 5.9 ** 40.4 ± 5.2 ** 
REM min 119.8 ± 7.7   101.4 ± 6.6   108.2 ± 8.6   100.9 ± 8.2   80.1 ± 5.5 ** 90.3 ± 5.1   95.0 ± 8.1   84.4 ± 4.5   
Wake min 39.6 ± 4.6   25.0 ± 7.3   82.2 ± 15.7   55.7 ± 9.3   107.9 ± 11.3 ** 73.9 ± 7.3 ** 93.5 ± 14.9   66.6 ± 8.3 ** 
Awakening index 1.64 ± 0.25   0.61 ± 0.14   2.84 ± 0.42   2.18 ± 0.23 ** 3.93 ± 0.65 ** 2.51 ± 0.22 ** 3.67 ± 0.67 * 2.84 ± 0.43 ** 
                 
 
* p<0.05, ** p<0,01 compared to young women 
# p<0.05 compared to perimenopausal women 
§ p<0.05 compared to off-HT postmenopausal women 
 
 
